Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOne Health Group Plc Regulatory News (OHGR.PL)

  • There is currently no data for OHGR.PL

Trading Update

10 Feb 2026 07:00

RNS Number : 3032S
One Health Group PLC
10 February 2026
 

 

One Health Group plc

("One Health", the "Company" or the "Group")

 

Trading Update

 

H2 trading remains strong with outlook unchanged

FY 26 Revenue and EBITDA growth remains in-line with expectations

Continued strong growth across all KPIs

 

One Health Group plc (AIM: OHGR), the independent provider of NHS-funded surgical procedures for patients referred from the NHS through 'Patient Choice', confirms that second half trading remains strong and the business is on track to deliver growth at the revenue and underlying EBITDA levels for the year ending 31 March 2026 (FY26) in-line with market expectations1, and at the higher end of the consensus revenue range. FY26 trading will show continued growth across all operational and financial key performance indicators.

 

1Management understands consensus market forecasts for revenue to range from £29.2m to £29.6m with underlying EBITDA for FY26 of £2.3m across consensus.

 

Update on first new-build surgical hub

The Company has received guidance that the final pre-commencement planning condition sign-off, relating to environmental matters, is expected to be confirmed within the coming weeks, with the remaining six pre-commencement conditions having already been satisfied. The Board remains confident that, once all planning condition signoffs are in place, the project will proceed in line with the anticipated one-year construction timetable, with contractors ready to start immediately. On completion, the new surgical hub is expected to provide significant additional surgical operating capacity and has the potential to materially enhance the Group's revenue and profitability.

 

Outlook

The Company has seen no change in trading performance towards the end of the financial year and remains well funded to deliver continued organic growth and execute the roll-out of the first surgical hub, accelerating growth and improving profitability. The Board is confident that the business will continue to deliver organic growth through increased new patient referrals, a strong pipeline of new surgeons, and additional surgical capacity in existing and new independent sector hospitals to help deliver on challenging Government Waiting List reduction targets.

 

Adam Binns, Chief Executive Officer, commented:

"We are delighted that our growth plans remain unaffected by wider concerns of reductions in elective surgery across England, and that we are in a strong position to continue to support the NHS in their aim to reduce national waiting lists from the current 7.3 million level.

 

"We work very effectively with multiple NHS commissioning bodies across a wide geography in addition to contracts directly with local NHS hospitals to support the reduction of internal 'long waits'. In any case, the vast majority of our activity is from brand new patients referred by their GP directly to One Health by exercising their legal right to choose their provider of care through 'patient choice'. We have seen increasing year on year demand in direct GP referrals as more and more new patients enter the system looking for treatment. As well as increased GP referrals, and as anticipated, we have also seen an increase in NHS hospital referrals in H2 supported by additional funding from the NHS 'quarter four sprint' initiative, where local NHS hospitals transfer NHS patients from their internal patient waiting lists."

 

"We are very proud to be a trusted provider of support to the NHS for over 21 years, with excellent long-standing relationships, and we continue to look forward to the future with confidence, providing much needed care, free at the point of delivery for NHS patients, across an ever-increasing geography, and reducing pressure on the NHS."

 

If you wish to keep up to date on Company news please email: onehealth@walbrookpr.com

For more information, please contact:

 

One Health Group plc

Derek Bickerstaff, Chairman

Adam Binns, CEO

 

www.onehealth.co.uk/investors

Via Walbrook PR

Panmure Liberum (Nominated Adviser and Broker)

Emma Earl, Will Goode, Mark Rogers

Rupert Dearden

 

Tel: +44 (0)20 3100 2000

Walbrook PR (Media & Investor Relations)

Alice Woodings / Paul McManus /

Rachel Broad

Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com

Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 /

+44 (0)7747 515 393

 

 

About One Health Group plc (www.onehealth.co.uk)

One Health engages 80 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and, in the year, to March 2025 provided much needed care to 17,020 new patients, through over 42,000 consultations and over 7,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 100 professionals across 9 independent hospitals and 37 outreach clinics. Within these community-based outreach clinics all consultations and post operative physiotherapy is delivered where required, reducing patient inconvenience and excess travel.

 

One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is derived from over 60 NHS commissioning bodies in addition to contracts with local NHS Hospital Trusts to transfer their internal waiting list patients to One Health for quicker treatment.

 

One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology, with urology introduced at the end of FY25.

 

Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.

 

Online investor presentation

Click below for the latest online presentation by Derek Bickerstaff, Chairman and Adam Binns, Chief Executive Officer, which offers insights into the Company's growth strategy and long-term vision:

https://sparklive.lseg.com/ONEHEALTHGROUP/events/3c988809-19ad-454c-af31-cfe86bfe7da5/one-health-group-half-year-results-announcement

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFRFAIAIIR
12
Date   Source Headline
22nd May 20269:30 amRNS-RPresentation at Mello2026
6th May 20267:00 amRNS-RAppointment of Commercial Manager
27th Apr 20267:00 amRNSFull Year Trading Update
7th Apr 20267:00 amRNSContract with Hospital renewed on longer terms
1st Apr 20267:00 amRNSBoard Changes
24th Feb 20267:00 amRNSPlanning sign off and Surgical Hub construction
23rd Feb 20264:33 pmRNSPlanning sign off and Surgical Hub construction
11th Feb 20267:00 amRNSFurther CEO share purchase
10th Feb 20263:45 pmRNSFurther CEO share purchase
10th Feb 20269:06 amRNSCEO share purchase
10th Feb 20267:00 amRNSTrading Update
2nd Feb 20263:09 pmRNSHolding(s) in Company
15th Dec 20253:19 pmRNSHolding(s) in Company
12th Dec 20252:10 pmRNSExercise of Warrants and Total Voting Rights
1st Dec 20257:00 amRNSHalf-year Financial Report
11th Nov 20257:00 amRNSNotice of Results and Investor Presentation
27th Oct 20257:00 amRNSTrading Update
24th Oct 20251:08 pmRNSExercise of Share Options & Total Voting Rights
12th Sep 202512:39 pmRNSResult of AGM and Voting Results
12th Sep 20257:00 amRNSAGM Statement
4th Jul 20254:04 pmRNSSuccessful planning application for Surgical Hub
23rd Jun 20257:00 amRNSFinal Results
16th Jun 202510:33 amRNSNotice of Results
28th May 20257:00 amRNS-RPresentation to Mello2025
24th Apr 20257:00 amRNSTrading Statement
31st Mar 20257:00 amRNSFull Planning Application Surgical Hub
25th Mar 202510:13 amGNWNOTICE TO DISREGARD: Form 8.3 - One Health Group plc - Octopus Investments
24th Mar 20253:40 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSHolding(s) in Company
21st Mar 20255:37 pmRNSHolding(s) in Company
21st Mar 20253:12 pmRNSHolding(s) in Company
21st Mar 20253:03 pmRNSTR1 - DRB capital raising
21st Mar 20252:59 pmRNSTR1 - EBT capital raising
21st Mar 20252:55 pmRNSDirector/PDMR Shareholding
20th Mar 20257:00 amRNSAdmission to trading on AIM and first day dealings
12th Mar 20252:17 pmRNSTR1
12th Mar 20252:13 pmRNSTR1
11th Mar 20253:32 pmRNSDirector Dealing
10th Mar 20251:24 pmRNSResults of GM and Open Offer
25th Feb 20257:00 amRNSResult of Retail Offer
19th Feb 20251:48 pmRNSResult of Placing
19th Feb 20257:05 amRNSRetail Offer for up to £0.5m
19th Feb 20257:00 amRNSCapital Raising and Proposed Admission to AIM
7th Jan 20257:00 amRNSAgreement
20th Dec 20247:00 amRNSHalf-year Report
29th Nov 20247:00 amRNSNotice of Results
28th Oct 20247:00 amRNSTrading Statement
30th Sep 20247:00 amRNSChange of Adviser
13th Sep 20243:55 pmRNSResult of AGM
24th Jun 20247:00 amRNSAnnual Financial Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.